canthin-6-one has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, DA; Ferreira, AT; Junior, MTR; Júnior, RTA; Justo, GZ; Lima, CS; Paredes-Gamero, EJ; Pilli, RA; Talhati, F; Torquato, HFV | 1 |
1 other study(ies) available for canthin-6-one and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
A canthin-6-one derivative induces cell death by apoptosis/necroptosis-like with DNA damage in acute myeloid cells.
Topics: Antineoplastic Agents; Apoptosis; Carbolines; Cell Death; Cell Line, Tumor; DNA Damage; Humans; Indole Alkaloids; Leukemia, Myeloid, Acute; MAP Kinase Signaling System; Necroptosis; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species | 2022 |